<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2248836&amp;fmt=gif">

MIM Software Inc. Announces FDA Clearance of Contour ProtégéAI® 4.0 Models

CLEVELAND, OH—May 10, 2023— MIM Software Inc., a leading global provider of medical imaging software, announced US Food and Drug Administration (FDA) clearance of its newest version of the AI auto-contouring solution Contour ProtégéAI. 

The update provides MIM Software® customers with iteratively improved algorithms for Radiation Oncology segmentation, additional structures, and enhancements for Molecular Radiotherapy (MRT).

With new FDA-cleared contours and the power of flexible implementation, Contour ProtégéAI can be added to any existing workflow with minimal effort and exceptional contouring results.

“Over the past several months, the MIM Software team has worked hard to focus this new version on improving our contouring performance,” said Jay Obman, Product Manager at MIM Software Inc. “The initial testing has shown a good improvement in our overall contour quality, and I’m excited for our users to reap the benefits of those improvements as well as some new contours we’ve added.”

To learn more about Contour ProtégéAI, click here

MIM Software
Written by MIM Software

MIM Software Inc. provides practical imaging solutions in radiation oncology, radiology, nuclear medicine, urology, neuroimaging, and cardiac imaging. MIM® offers solutions for computer workstations as well as mobile and cloud-based platforms. MIM products are sold globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies.

You can visit them online at